West Lafayette, IN, United States of America

Casey J Krusemark

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Purdue Research Foundation. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Casey J Krusemark. Retrieved from https://idiyas.com/inventor/casey-j-krusemark-xor0wv6d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 80.0

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Casey J Krusemark

Introduction

Casey J Krusemark is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of biochemistry and pharmacology, holding a total of 5 patents. His work focuses on developing innovative methods and compounds that have the potential to impact drug discovery and treatment.

Latest Patents

Among his latest patents is the invention titled "Affinity labeling of DNA-linked ligands for high throughput ligand binding assays and the uses thereof." This patent describes an assay method that utilizes affinity crosslinking of DNA-linked ligands to proteins. This method enables small molecule screening and the determination of apparent affinity constants of ligands to proteins. It has been successfully applied to determine the dissociation constants of 96 compounds to a protein target simultaneously. Additionally, it allows for the direct determination of a compound's IC against five protein targets concurrently in crude cell lysates. This innovative approach was also used to screen a Library of Pharmacologically Active Compounds (LOPAC) against dihydrofolate reductase (eDHFR), leading to the discovery of a novel eDHFR inhibitor with an IC50 of 7.9 μM. An assay kit and the method of uses are included within the scope of this disclosure.

Another significant patent is "CBX8 chromdomain inhibitors and the uses thereof." This invention relates to a series of peptidomimetic compounds that selectively target CBX8 of polycomb chromobox protein homolog proteins. The patent covers pharmaceutical compositions of these compounds and methods for using them in the treatment of diseases associated with CBX8 pharmacology, including various cancers and leukemia. The compounds can be administered alone or in combination with other therapeutics to achieve therapeutic effects.

Career Highlights

Casey J Krusemark is affiliated with the Purdue Research Foundation, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in the pharmaceutical industry.

Collaborations

He collaborates with talented individuals such as Sijie Wang and Dongwook Kim, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Casey J Krusemark's contributions to the field of biochemistry and pharmacology through his patents and research are noteworthy. His innovative methods and compounds hold promise for advancing

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…